Quantitative analysis of CMV DNA in children the first year after liver transplantation

Pediatric Transplantation

Volumn 7, Issue 4, 2003, Pages 296-301

  Kullberg Lindh, Carola ^a,b   Ascher, Henry ^a   Krantz, Marie ^a   Lindh, Magnus ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Cytomegalovirus; Immunosuppression; Polymerase chain reaction

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC KIT; DNA DETERMINATION; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LATENT VIRUS INFECTION; LIVER TRANSPLANTATION; MALE; PEDIATRIC SURGERY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; DNA, VIRAL; FEMALE; HUMANS; IMMUNOGLOBULIN M; INFANT; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES;

EID: 0042736161     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2003.00086.x     Document Type: Article

References (23)

1. STRATTA RJ, SHAEFER MS, MARKIN RS et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989: 124: 1443-1450.
2. KING SM, PETRIC M, SUPERINA R, GRAHAM N, ROBERTS EA. Cytomegalovirus infections in pediatric liver transplantation. Am J Dis Child 1990: 144: 1307-1310.
3. GUPTA P, HART J, CRONIN D, KELLY S, MILLIS JM, BRADY L. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation 2001: 72: 1098-1102.
4. FIETZE E, PROSCH S, REINKE P et al. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 1994: 58: 675-680.
5. MANEZ R, BREINIG MC, LINDEN P et al. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997: 176: 1462-1467.
6. FALAGAS ME, SNYDMAN DR, GRIFFITH J, WERNER BG. Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group. Clin Infect Dis 1996: 23: 468-474.
7. GEORGE MJ, SNYDMAN DR, WERNER BG et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med 1997: 103: 106-113.
8. PAYA CV, HERMANS PE, WASHINGTON JA II et al. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 1989: 64: 555-564.
9. GREEN M, TZAKIS A, REYES J, NOUR B, TODO S, STARZL TE. Infectious complications of pediatric liver transplantation under FK 506. Transplant Proc 1991: 23: 3038-3039.
10. SUTHERLAND S, BRACKEN P, WREGHITT TG, O'GRADY J, CALNE RY, WILLIAMS R. Donated organ as a source of cytomegalovirus in orthotopic liver transplantation. J Med Virol 1992: 37: 170-173.
11. MARKIN RS, STRATTA RJ, WOODS GL. Infection after liver transplantation. Am J Surg Pathol 1990: 14 (Suppl. 1): 64-78.
12. EMERY VC, SABIN CA, COPE AV, GOR D, HASSAN-WALKER AF, GRIFFITHS PD. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000: 355: 2032-2036.
13. SIA IG, WILSON JA, GROETTUM CM et al. DNA load predicts relapsing CMV infection after solid organ transplantation. J Infect Dis 2000: 181: 717-720.
14. BAI X, ROGERS BB, HARKINS PC et al. Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients. J Mol Diagn 2000: 2: 191-201.
15. AW MM, MURUGASU B, TAN AW, SEAH CC, BALAKRISHNAN V, YAP HK. Quantitation of peripheral blood cytomegalovirus DNA for monitoring recurrent cytomegalovirus retinitis in pediatric solid organ transplant recipients. Pediatr Transplant 2000: 4: 100-106.
16. SIA IG, WILSON JA, ESPY MJ, PAYA CV, SMITH TF. Evaluation of the Cobas Amplicor CMV Monitor test for detection of viral DNA in specimens taken from patients after liver transplantation. J Clin Microbiol 2000: 38: 600-606.
17. CALIENDO AM, SCHUURMAN R, YEN-LIEBERMAN B et al. Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol 2001: 39: 1334-1338.
18. FLEXMAN J, KAY I, FONTE R, HERRMANN R, GABBAY E, PALLADINO S. Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients. J Med Virol 2001: 64: 275-282.
19. RAZONABLE RR, BROWN RA, ESPY MJ et al. Comparative Quantitation of Cytomegalovirus (CMV) DNA in Solid Organ Transplant Recipients with CMV Infection by Using Two High-Throughput Automated Systems. J Clin Microbiol 2001: 39: 4472-4476.
20. STUDAHL M, RICKSTEN A, SANDBERG T et al. Cytomegalovirus infection of the CNS in non-compromised patients. Acta Neurol Scand 1994: 89: 451-457.
21. EVANS PC, SOIN A, WREGHITT TG, ALEXANDER GJ. Qualitative and semiquantitative polymerase chain reaction testing for cytomegalovirus DNA in serum allows prediction of CMV related disease in liver transplant recipients. J Clin Pathol 1998: 51: 914-921.
22. LIMAYE AP, COREY L, KOELLE DM, DAVIS CL, BOECKH M. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 2000: 356: 645-649.
23. SCHAADE L, KOCKELKORN P, RITTER K, KLEINES M. Detection of cytomegalovirus DNA in human specimens by LightCycler PCR. J Clin Microbiol 2000: 38: 4006-4009.